Received Dec 15, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| PNC20 | PNEUMO (PREVNAR20) | PFIZER\WYETH | 1 | MG7416 | IM / LA |
65yo male patient with medical history of centrilobular emphysema, nicotine dependence (in remission), HTN, prediabetes, and hyperlipidemia, received pneumococcal vaccine on 11/3/25 in provider's office. Patient went to Hospital c/o severe dizziness and double vision. Admitted 11/18, negative stroke workup, discharged home 11/23. Diagnosis of Guillain-Barre Syndrome with eye paralysis and double vision. Cardiology and Neuro-ophthalmology outpatient follow up.
No acute illness reported at primary care visit on 11/3/25.
Hypertension, hyperlipidemia, centrilobular emphysema, dyspnea, cigarette nicotine dependence in remission, prediabetes, hypercholesterolemia, obesity
Losartan (Cozaar) 50 mg tablet, Crestor 10 mg Tablet, Albuterol 180 mcg/Act Inhaler, Meclizine 12.5 mg Tablet
No known allergies.
Patient was admitted on 11/18/25 and discharged home 11/23/25. During admission, Brain CT and MRI were performed, negative for acute stroke. Chest XR, carotid doppler, and CT angiogram of the head and neck were also performed, all were reported as negative. Lumbar puncture was performed that revealed increased proteins. Patient was started on treatment with intravenous immunoglobulins for possible early Guillain-Barre syndrome. Echocardiogram was also performed during the hospital stay that showed a possible perforated foramen, recommended further workup with outpatient cardiologist.